0,989  0,001  Monophenol monooxygenase inhibitor
0,918  0,003  Antioxidant
0,898  0,006  Apoptosis agonist
0,863  0,005  Antineoplastic (breast cancer)
0,845  0,002  Hepatoprotectant
0,801  0,004  Hepatic disorders treatment
0,805  0,008  Antineoplastic (lung cancer)
0,788  0,004  Nitric oxide antagonist
0,757  0,005  Caspase 3 stimulant
0,760  0,021  Antiinflammatory
0,747  0,018  Caspase 9 stimulant
0,734  0,017  Transcription factor NF kappa B inhibitor
0,680  0,011  Prostate cancer treatment
0,626  0,007  Free radical scavenger
0,615  0,011  Cytostatic
0,593  0,014  Immunosuppressant
0,587  0,014  Chemopreventive
0,596  0,025  Antileukemic
0,568  0,012  NOS2 expression inhibitor
0,553  0,007  Antihypertriglyceridemic
0,549  0,018  Antineoplastic (melanoma)
0,538  0,016  UGT1A9 substrate
0,531  0,018  Cardioprotectant
0,526  0,015  Antineoplastic (glioma)
0,526  0,017  AR expression inhibitor
0,517  0,018  NOS3 expression inhibitor
0,506  0,007  Melanin inhibitor
0,506  0,013  Amyloid beta aggregation inhibitor
0,516  0,044  Alzheimer's disease treatment
0,494  0,023  Antineoplastic (cervical cancer)
0,478  0,008  Skin whitener
0,489  0,037  Antineoplastic (colorectal cancer)
0,456  0,007  Lipid peroxidase inhibitor
0,490  0,044  Antibacterial
0,434  0,009  Topoisomerase II inhibitor
0,435  0,017  UDP-glucuronosyltransferase substrate
0,456  0,040  Antineoplastic (colon cancer)
0,437  0,022  Antineoplastic (glioblastoma multiforme)
0,419  0,007  NOS3 expression enhancer
0,436  0,030  Apoptosis antagonist
0,426  0,021  UGT1A6 substrate
0,425  0,039  Antihypercholesterolemic
0,427  0,043  Antiprotozoal (Plasmodium)
0,405  0,020  Antineoplastic (osteosarcoma)
0,396  0,016  Antimutagenic
0,440  0,064  TNF expression inhibitor
0,401  0,027  Hypoglycemic
0,405  0,034  Chemoprotective
0,394  0,039  Antineoplastic (pancreatic cancer)
0,382  0,032  Proliferative diseases treatment
0,394  0,045  Antineoplastic (ovarian cancer)
0,373  0,037  UGT2B4 substrate
0,339  0,008  Topoisomerase I inhibitor
0,357  0,031  Antimitotic
0,322  0,003  Papain-like protease (SARS coronavirus) inhibitor
0,343  0,036  Antineoplastic (liver cancer)
0,324  0,018  Antiviral (Hepatitis)
0,331  0,026  UGT1A1 substrate
0,351  0,051  Antineoplastic (brain cancer)
0,307  0,008  Antihemorrhagic
0,311  0,016  UGT2B15 substrate
0,284  0,005  T cell inhibitor
0,343  0,065  ICAM1 expression inhibitor
0,295  0,022  UGT1A3 substrate
0,284  0,024  Antineoplastic (squamous cell carcinoma)
0,267  0,012  Antineoplastic antibiotic
0,346  0,094  Antiprotozoal
0,307  0,062  Hypoxia-inducible factor 1 alpha inhibitor
0,265  0,020  Antiviral (Hepatitis C)
0,308  0,063  CYP2C19 substrate
0,250  0,010  Topoisomerase II alpha inhibitor
0,242  0,005  Lipase inhibitor
0,285  0,048  Antineoplastic (sarcoma)
0,252  0,020  Acetylcholinesterase inhibitor
0,297  0,069  CYP1A2 substrate
0,288  0,072  Antiosteoporotic
0,239  0,024  Genotoxic
0,261  0,048  Antihypotensive
0,269  0,064  Antiprotozoal (Leishmania)
0,232  0,030  Antiviral (Influenza A)
0,244  0,049  Antiviral (Influenza)
0,293  0,104  CYP3A4 substrate
0,261  0,073  Antineoplastic (non-small cell lung cancer)
0,225  0,036  Cholinergic
0,197  0,010  HIV-1 integrase (3'-Processing) inhibitor
0,276  0,093  Antifungal
0,191  0,012  Creatine kinase inhibitor
0,187  0,015  Estrogen antagonist
0,212  0,057  P-glycoprotein inhibitor
0,181  0,029  Cystathionine beta-synthase inhibitor
0,253  0,106  CTGF expression inhibitor
0,152  0,005  Antiviral (Hepatitis A)
0,274  0,128  CYP2C9 substrate
0,229  0,086  Tumour necrosis factor alpha release inhibitor
0,187  0,046  Protein kinase stimulant
0,214  0,073  Cytotoxic
0,192  0,058  Antineoplastic (gastric cancer)
0,219  0,087  Antiamyloidogenic
0,142  0,013  Postmenopausal disorders treatment
0,175  0,047  Tubulin antagonist
0,245  0,117  Bone diseases treatment
0,143  0,018  SULT1E1 substrate
0,164  0,039  Interleukin 4 antagonist
0,162  0,039  Cholesterol synthesis inhibitor
0,170  0,048  SULT1A3 substrate
0,175  0,055  Antineoplastic (carcinoma)
0,203  0,083  Nitric-oxide synthase stimulant
0,138  0,019  Estrogen receptor beta antagonist
0,145  0,030  Carbonic anhydrase III inhibitor
0,135  0,025  Antiviral (SARS coronavirus)
0,135  0,025  Antiviral (Coronavirus)
0,153  0,044  Protein-tyrosine phosphatase 1B inhibitor
0,123  0,016  HIV-1 integrase (Strand Transfer) inhibitor
0,144  0,040  Antineoplastic (uterine cancer)
0,195  0,098  Antiviral (HIV)
0,218  0,126  Antineoplastic (multiple myeloma)
0,104  0,016  Estrogen agonist
0,251  0,164  15-Lipoxygenase inhibitor
0,098  0,012  Estrogen receptor beta agonist
0,138  0,056  DNA polymerase I inhibitor
0,212  0,132  CYP2D6 substrate
0,123  0,044  Carbonic anhydrase XV inhibitor
0,159  0,081  UGT2B7 substrate
0,120  0,045  Sulfotransferase substrate
0,118  0,050  UGT2B1 substrate
0,147  0,081  Protein-tyrosine phosphatase inhibitor
0,170  0,110  Angiogenesis stimulant
0,115  0,055  Electron transport complex I inhibitor
0,177  0,120  VCAM1 expression inhibitor
0,116  0,060  DNA intercalator
0,096  0,042  Carbonic anhydrase VI inhibitor
0,120  0,070  M18 aspartyl aminopeptidase inhibitor
0,184  0,136  Lipoprotein disorders treatment
0,167  0,124  VEGF expression inhibitor
0,081  0,039  Antitreponemal
0,042  0,004  Toll-Like receptor 4 agonist
0,110  0,073  Microtubule formation inhibitor
0,224  0,189  Antineoplastic (small cell lung cancer)
0,068  0,035  Nitric oxide donor
0,062  0,029  Alpha tubulin antagonist
0,162  0,132  Antineoplastic enhancer
0,066  0,037  Aromatase inhibitor
0,129  0,102  UGT1A4 substrate
0,092  0,068  Xanthine oxidase inhibitor
0,097  0,075  Beta glucuronidase inhibitor
0,155  0,135  Aldehyde oxidase inhibitor
0,073  0,055  Carbonic anhydrase XIII inhibitor
0,039  0,024  Nicotinic receptor beta4 subunit antagonist
0,072  0,058  Na+ K+ transporting ATPase inhibitor
0,034  0,020  Estrogen-related receptor beta antagonist
0,125  0,111  UGT2B9 substrate
0,141  0,131  Antineoplastic (bone cancer)
0,068  0,059  Antibiotic
0,049  0,040  Aldose reductase inhibitor
0,032  0,025  Estrogen receptor alpha agonist
0,082  0,076  Breast cancer-resistant protein inhibitor
0,087  0,082  UGT2B11 substrate
0,127  0,123  Sensitization
0,135  0,134  UGT2B10 substrate
0,089  0,088  HDL-cholesterol increasing

